CalciMedica
CalciMedica is engaged in the discovery and development of small molecule drugs for the treatment of acute and chronic inflammatory diseases and autoimmune disorders. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
CAD115—172m (Dealroom.co estimates Mar 2021.)
San Diego California (HQ)
Authorizing premium user...